Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C38H73N21O10S2 |
Molecular Weight | 1048.251 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O
InChI
InChIKey=ANIAZGVDEUQPRI-ZJQCGQFWSA-N
InChI=1S/C38H73N21O10S2/c1-18(28(62)56-22(27(40)61)8-4-12-49-35(41)42)53-30(64)23(9-5-13-50-36(43)44)58-32(66)25(11-7-15-52-38(47)48)59-31(65)24(10-6-14-51-37(45)46)57-29(63)19(2)54-33(67)26(55-20(3)60)17-71-70-16-21(39)34(68)69/h18-19,21-26H,4-17,39H2,1-3H3,(H2,40,61)(H,53,64)(H,54,67)(H,55,60)(H,56,62)(H,57,63)(H,58,66)(H,59,65)(H,68,69)(H4,41,42,49)(H4,43,44,50)(H4,45,46,51)(H4,47,48,52)/t18-,19-,21+,22-,23-,24-,25-,26-/m1/s1
Molecular Formula | C38H73N21O10S2 |
Molecular Weight | 1048.251 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 20:19:18 UTC 2023
by
admin
on
Fri Dec 15 20:19:18 UTC 2023
|
Record UNII |
60ME133FJB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
H05BX04
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
||
|
NCI_THESAURUS |
C78275
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
||
|
FDA ORPHAN DRUG |
567616
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
||
|
NDF-RT |
N0000175902
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
60ME133FJB
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
71511839
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
DB12865
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
Etelcalcetide
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
SUB178987
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
CHEMBL3545184
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
DTXSID70155132
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
100000164426
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
60ME133FJB
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
ZZ-124
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
C129712
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
5181
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
m11978
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
1262780-97-1
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
9809
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY | |||
|
1876119
Created by
admin on Fri Dec 15 20:19:18 UTC 2023 , Edited by admin on Fri Dec 15 20:19:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
Etelcalcetide is primarily bound to plasma albumin and the plasma non-covalent protein binding is less than 50%.
BINDING
|
||
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||